Sentisearch, Inc. (SSRC)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Sentisearch, Inc. (SSRC) with AI Score 57/100 (Hold). SentiSearch, Inc. is a development stage company focused on insect chemosensation and olfaction technologies. Market cap: 0, Sector: Industrials.
Last analyzed: Mar 16, 2026Sentisearch, Inc. (SSRC) Industrial Operations Profile
SentiSearch, Inc., founded in 2000, operates as a development stage company within the specialty business services sector, focusing on insect chemosensation and olfaction. The company holds licenses and patent applications related to insect receptor genes, with the goal of developing and commercializing products and services in this niche area.
Investment Thesis
SentiSearch, Inc. presents a high-risk, high-reward investment opportunity due to its early development stage and focus on a niche market. The company's value hinges on its ability to successfully develop and commercialize products and services based on its licensed technologies and patent applications in insect chemosensation and olfaction. With a negative P/E ratio of -0.01 and a profit margin of -549.7%, the company's financial performance is currently unsustainable. Key catalysts include successful research outcomes and strategic partnerships. The high beta of 9.98 indicates significant volatility. Investors should carefully consider the risks associated with development stage companies and the uncertainty surrounding the commercial viability of SentiSearch's technologies.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.00B, reflecting its status as a micro-cap or nano-cap company.
- Negative P/E ratio of -0.01, indicating the company is not currently profitable.
- Profit margin of -549.7%, highlighting significant losses relative to revenue.
- Gross margin of 100.0%, suggesting high potential profitability if the company can generate substantial revenue.
- Beta of 9.98, indicating very high volatility compared to the overall market.
Competitors & Peers
Strengths
- Exclusive license in a niche technology area.
- Patent applications for insect receptor genes.
- Potential for innovative pest control solutions.
- High gross margin potential (100%).
Weaknesses
- Development stage company with no current revenue.
- Significant losses and negative profit margin (-549.7%).
- High beta indicating high volatility.
- Small company size with only 1 employee.
Catalysts
- Upcoming: Successful results from ongoing research and development efforts.
- Upcoming: Securing strategic partnerships with research institutions or industry players.
- Upcoming: Obtaining regulatory approvals for new pest control products.
- Ongoing: Licensing of intellectual property to generate revenue.
Risks
- Potential: Failure to successfully develop and commercialize its technologies.
- Potential: Competition from larger, more established companies.
- Potential: Regulatory hurdles for new pest control products.
- Ongoing: Dependence on securing additional funding.
- Ongoing: Limited liquidity due to OTC Other tier status.
Growth Opportunities
- Development of Novel Pest Control Solutions: SentiSearch can leverage its expertise in insect chemosensation to develop innovative pest control products. The global pest control market is estimated to reach $30 billion by 2028, offering a substantial opportunity for companies with effective and environmentally friendly solutions. Timeline: 3-5 years for product development and regulatory approvals.
- Applications in Agriculture: Insect chemosensation plays a crucial role in plant-insect interactions. SentiSearch can develop technologies to enhance crop protection and improve agricultural yields. The precision agriculture market is projected to reach $12.9 billion by 2027, providing a potential market for SentiSearch's technologies. Timeline: 2-4 years for research and development.
- Environmental Monitoring: Insect chemosensors can be used to detect pollutants and monitor environmental conditions. SentiSearch can develop sensor-based solutions for environmental monitoring applications. The environmental monitoring market is expected to reach $27.9 billion by 2028, creating opportunities for specialized sensor technologies. Timeline: 3-5 years for sensor development and deployment.
- Partnerships with Research Institutions: Collaborating with universities and research institutions can accelerate the development and validation of SentiSearch's technologies. These partnerships can provide access to funding, expertise, and infrastructure. Timeline: Ongoing, with continuous collaboration efforts.
- Licensing of Intellectual Property: SentiSearch can generate revenue by licensing its patents and technologies to other companies in related industries. This can provide a low-risk revenue stream and expand the reach of its technologies. Timeline: Ongoing, with continuous licensing efforts.
Opportunities
- Growing market for pest control solutions.
- Potential applications in agriculture and environmental monitoring.
- Partnerships with research institutions.
- Licensing of intellectual property.
Threats
- Competition from larger, more established companies.
- Regulatory hurdles for new pest control products.
- Uncertainty surrounding the commercial viability of its technologies.
- Dependence on securing additional funding.
Competitive Advantages
- Patents and patent applications related to insect receptor genes.
- Exclusive license to develop products and services in its niche area.
- Specialized expertise in insect chemosensation and olfaction.
About SSRC
Founded in 2000, SentiSearch, Inc. is a development stage company operating within the specialty business services sector. The company's core focus lies in the realm of insect chemosensation and olfaction, leveraging licensed technologies and patent applications to develop products and services. SentiSearch holds a license enabling it to develop, manufacture, import, sell, and distribute products related to insect chemosensation and olfaction. The company's intellectual property portfolio includes patent applications pertaining to nucleic acids and proteins of insect or odorant receptor genes. Currently based in New York, the company's activities are centered around research and development, with the long-term objective of commercializing its technologies. As a development stage company, SentiSearch is pre-revenue and focused on advancing its research and development efforts.
What They Do
- Holds a license to develop products and services in insect chemosensation and olfaction.
- Aims to manufacture products related to insect chemosensation and olfaction.
- Intends to import products and services in the specified areas.
- Plans to use its technology to create new products and services.
- Seeks to sell and distribute its products in the market.
- May rent or lease its products to customers.
Business Model
- Developing and commercializing products based on insect chemosensation and olfaction technologies.
- Licensing its intellectual property to other companies.
- Generating revenue through sales, distribution, and rental/leasing of its products.
Industry Context
SentiSearch, Inc. operates within the specialty business services sector, focusing on the niche area of insect chemosensation and olfaction. This sector involves companies providing specialized services to various industries, often requiring unique expertise and intellectual property. The market for insect chemosensation technologies is relatively small but has potential applications in areas such as pest control, agriculture, and environmental monitoring. SentiSearch faces competition from companies with broader expertise in biotechnology and chemical sensing, including BBRW (BrewBilt Manufacturing Inc.), IMHCW (Immunocore Holdings plc Warrants), LEAS (Lease Corporation of America), PSGI (Premier Security Group, Inc.), and RNWR (RenovoRx, Inc.).
Key Customers
- Potential customers in the pest control industry.
- Agricultural companies seeking crop protection solutions.
- Environmental monitoring agencies and organizations.
Financials
Chart & Info
Sentisearch, Inc. (SSRC) stock price: Price data unavailable
Latest News
No recent news available for SSRC.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SSRC.
Price Targets
Wall Street price target analysis for SSRC.
MoonshotScore
What does this score mean?
The MoonshotScore rates SSRC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Specialty Business ServicesLeadership: Joseph K. Pagano
CEO
Joseph K. Pagano is the CEO of SentiSearch, Inc. His background and experience prior to joining SentiSearch are not detailed in the provided information. As the head of a development stage company, his role involves overseeing the company's research and development efforts, securing funding, and establishing strategic partnerships.
Track Record: Due to the limited information available, it is difficult to assess Joseph K. Pagano's track record at SentiSearch. The company is still in the development stage, and there are no significant milestones or achievements to report at this time.
SSRC OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that SentiSearch, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it difficult for investors to assess their financial health and operations. This tier is often associated with higher risk and greater potential for fraud compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure due to OTC Other tier status.
- Low liquidity and wide bid-ask spreads.
- Potential for price manipulation and fraud.
- Higher risk of delisting or going out of business.
- Limited regulatory oversight compared to major exchanges.
- Verify the company's registration and legal status.
- Review any available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Patent applications related to insect receptor genes.
- Exclusive license to develop products in its niche area.
- Company has been in existence since 2000.
- Presence of a CEO (Joseph K. Pagano).
What Investors Ask About Sentisearch, Inc. (SSRC)
What does Sentisearch, Inc. do?
SentiSearch, Inc. is a development stage company focused on insect chemosensation and olfaction. It holds a license to develop, manufacture, and sell products and services related to insect receptor genes. The company aims to create innovative solutions for pest control, agriculture, and environmental monitoring by leveraging its intellectual property and specialized expertise in this niche area.
What do analysts say about SSRC stock?
As a development stage company trading on the OTC market, SentiSearch, Inc. is unlikely to have analyst coverage. Investors should conduct their own due diligence and carefully consider the risks associated with investing in micro-cap and OTC stocks. Key valuation metrics include the company's intellectual property portfolio, potential market size, and ability to secure funding and partnerships. Growth considerations include successful product development and commercialization.
What are the main risks for SSRC?
The main risks for SentiSearch, Inc. include its development stage status, dependence on securing additional funding, competition from larger companies, regulatory hurdles, and limited liquidity due to its OTC Other tier listing. The company's success hinges on its ability to successfully develop and commercialize its technologies, which is subject to significant uncertainty and risk.
What are the key factors to evaluate for SSRC?
Sentisearch, Inc. (SSRC) currently holds an AI score of 57/100, indicating moderate score. Key strength: Exclusive license in a niche technology area.. Primary risk to monitor: Potential: Failure to successfully develop and commercialize its technologies.. This is not financial advice.
How frequently does SSRC data refresh on this page?
SSRC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven SSRC's recent stock price performance?
Recent price movement in Sentisearch, Inc. (SSRC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Exclusive license in a niche technology area.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider SSRC overvalued or undervalued right now?
Determining whether Sentisearch, Inc. (SSRC) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying SSRC?
Before investing in Sentisearch, Inc. (SSRC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on SentiSearch, Inc.
- OTC market investments are inherently risky.
- Financial data may not be up-to-date.